You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Bioelectronic Fusion Sensor System

    SBC: SENTIENT SCIENCE CORPORATION            Topic: N14AT019

    To address the Navy"s need for a common, scalable, platform for multi-modal 1pA level current sensing for Electrocardiogram (ECG), Electroencephalogram (EEG), and Electrodermal Response (EDR) to be fielded as a miniature wearable device with non-contact electrodes, Sentient and the State University of New York (SUNY) propose to develop the Bioelectronic Fusion Sensor System (BioFuSenS) that will a ...

    STTR Phase I 2014 Department of DefenseNavy
  2. Electrical Energy Storage System by SMES Method for Ultra-High Power and Energy Density

    SBC: TAI-YANG RESEARCH COMPANY            Topic: AF11BT31

    ABSTRACT: The Tai-Yang Research Company (TYRC) of Tallahassee, FL in collaboration with Dr. Justin Schwartz of the North Carolina State University (NCSU) in Raleigh, NC propose in this Phase 2 effort to develop the critical technologies necessary for the implementation and operation of an airborne high temperature superconductor (HTS) superconducting magnetic energy storage (SMES) device with par ...

    STTR Phase II 2014 Department of DefenseAir Force
  3. Decision Making under Uncertainty for Dynamic Spectrum Access

    SBC: INFOBEYOND TECHNOLOGY LLC            Topic: AF13AT02

    ABSTRACT: Due to scarcity of spectrum, Dynamic Spectrum Access (DSA) becomes a needed technology to improve the utilization of electromagnetic spectrum for DoD satellite communication. However, current DSA approaches are developed for terrestrial communications without addressing the unique challenges for SATCOM environments such as error-prone spectrum sensing, high mobility, and large coverage. ...

    STTR Phase I 2014 Department of DefenseAir Force
  4. Secure Efficient Cross-domain Protocols

    SBC: INFOBEYOND TECHNOLOGY LLC            Topic: AF13AT08

    ABSTRACT: Coordinating and sharing information across multi-level security (MLS) networks are of great interest in many military applications. However, it is very challenging to accomplish those goals due to the heterogeneous security classifications of different network domains. The recent proposed cross-domain solutions (CDS) provide initial steps to make such applications possible. However, th ...

    STTR Phase I 2014 Department of DefenseAir Force
  5. Software for the Design and Certification of Unitized Airframe Components

    SBC: VEXTEC Corporation            Topic: AF05T015

    This SBIR Phase I will demonstrate the feasibility for a unitized component structural design tool that allows for holistic risk assessment. The analysis will transform the FEA predicted stress (or strain) state into fully probabilistic assessment of uncertainty in geometry and loading throughout the component. Thereafter the design tool will conduct probabilistic microstructural damage accumulati ...

    STTR Phase I 2005 Department of DefenseAir Force
  6. Gene Expression and Diagnosis of Diabetes

    SBC: ARTHROCHIP, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Autoimmune diseases are difficult to diagnose, as the symptoms can be nonspecific. A single test that could readily distinguish between an autoimmune and non-autoimmune disorder would allow physicians to focus efforts on the specific disease that affects the patient. This is critical for diabetes mellitus (DM), which has two subsets, Type I and Type II. The sub ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  7. High Purity Amphotericin B: A Safer Antimycotic in AIDS

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cumberland Pharmaceuticals and the University of Mississippi Mycotic Research Centers' long-term goal will be to improve anti-fungal pharmacotherapy particularly for patients with human immunodeficiency infections (HIV). We are jointly developing a high purity amphotericin B (AmB HP) product for intravenous administration. The nominal purity of AmB HP is 95%; ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  8. New anti-complement therapy to reduce reperfusion injury

    SBC: ENDOPROTECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this proposal is to provide proof-of-concept that a novel therapy that prevents complement activation could be effective in reducing ischemia reperfusion injury (IRI) in transplanted organs. Complement activation after IRI in transplanted organs is a well-known phenomenon that may be responsible for delayed graft function and the hastening of ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Enhancement of the Baculovirus Expression Vector System

    SBC: PARATECHS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): The baculovirus expression vector system (BEVS) is one of the most powerful and versatile eukaryotic expression systems. The BEVS is being used to produce antigens for vaccine development, to manufacture human therapeutics, to develop faster acting biological insecticides and as a protein expression system for a multitude of research project. However, a limita ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Realistic Phantom Series for OLINDA/EXM Version 2

    SBC: RADAR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The OLINDA/EXM code, which replaces the popular MIRDOSE code for calculating dose estimates in nuclear medicine applications, was given an exemption by the FDA on June 15, 2004 to be distributed as a medical device. The code will have a 3 year lifetime, and may be considered for re-release in June of 2007. The current code contains the traditional phantom typ ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government